Efficacy and Safety of TLL-018 in Moderate to Severe Chronic Spontaneous Urticaria Patients with Inadequate Response to H1 Antihistamine: Results from a Phase b Study

被引：0
|
作者：
Lu, Qianjin [1 ]
Yang, Bin [2 ]
Liu, Lunfei [3 ]
Li, Linfeng [4 ]
Liu, Weijun [5 ]
Yao, Xu [1 ]
Man, Xiaoyong [6 ]
Chen, Aijun [7 ]
Shi, Yuling [8 ]
Ding, Yangfeng [8 ]
Sun, Qing [9 ]
Tao, Juan [10 ]
Liang, Chris [11 ]
Liu, Yong [11 ]
Liu, Donghua [11 ]
Sun, Peiyu [11 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Dermatol, Beijing, Peoples R China
[2] Southern Med Univ, Dermatol Hosp, Guangzhou, Peoples R China
[3] Zhejiang Univ, Sch Med, Affiliated Hosp 4, Hangzhou, Peoples R China
[4] Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China
[5] Dermatol Hosp Jiangxi Prov, Nanchang, Jiangxi, Peoples R China
[6] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Hangzhou, Peoples R China
[7] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China
[8] Tongji Univ, Sch Med, Shanghai Skin Dis Hosp, Shanghai, Peoples R China
[9] Shandong Univ, Qilu Hosp, Jinan, Peoples R China
[10] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China
[11] Hangzhou Highlightll Pharmaceut Co Ltd, Hangzhou, Peoples R China
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2024年 / 153卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
L36
引用
收藏
页码：AB372 / AB372
页数：1
相关论文
共 50 条
  • [1] Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamine
    Curtortorto-Barredo, Laia
    Gimenez-Arnau, Ana M.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2019, 154 (04): : 444 - 456
  • [2] Efficacy and safety of omalizumab in patients with chronic idiopathic urticaria who remain symptomatic despite concomitant H1 antihistamine therapy: results of a phase 2 trial
    Saini, S.
    Rosen, K.
    Hsieh, H.
    Wong, D.
    Conner, E.
    Doyle, R.
    Kaplan, A.
    Spector, S.
    Maurer, M.
    ALLERGY, 2011, 66 : 33 - 33
  • [3] Fenebrutinib in H1 antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trial
    Martin Metz
    Gordon Sussman
    Rémi Gagnon
    Petra Staubach
    Tonny Tanus
    William H. Yang
    Jeremy J. Lim
    Holly J. Clarke
    Joshua Galanter
    Leslie W. Chinn
    Tom Chu
    Anastasia Teterina
    Tracy Burgess
    D. James Haddon
    Timothy T. Lu
    Marcus Maurer
    Nature Medicine, 2021, 27 : 1961 - 1969
  • [4] Fenebrutinib in H1 antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trial
    Metz, Martin
    Sussman, Gordon
    Gagnon, Remi
    Staubach, Petra
    Tanus, Tonny
    Yang, William H.
    Lim, Jeremy J.
    Clarke, Holly J.
    Galanter, Joshua
    Chinn, Leslie W.
    Chu, Tom
    Teterina, Anastasia
    Burgess, Tracy
    Haddon, D. James
    Lu, Timothy T.
    Maurer, Marcus
    NATURE MEDICINE, 2021, 27 (11) : 1961 - +
  • [5] The efficacy and safety of the up-dosing of second-generation H1 antihistamine in treatment of chronic spontaneous urticaria in a paediatric population
    Sarti, L.
    Mori, F.
    Barni, S.
    Liccioli, G.
    Giovannini, M.
    Novembre, E.
    ALLERGY, 2019, 74 : 30 - 30
  • [6] Association of ORAI1 gene polymorphisms with chronic spontaneous urticaria and the efficacy of the nonsedating H1 antihistamine desloratadine
    Li, Jie
    Guo, Aiyuan
    Chen, Wangqing
    Bin, Lianghua
    He, Yijing
    Zhu, Wu
    Peng, Cong
    Yan, Siyu
    Chen, Mingliang
    Zhang, Jianglin
    Su, Juan
    Yi, Mei
    Liu, Zhaoqian
    Zhang, Wei
    Zeng, Weiqi
    Leung, Donald Y. M.
    Chen, Xiang
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (04) : 1386 - 1388
  • [7] HEAD-TO-HEAD COMPARISON OF TLL-018 AND TOFACITINIB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: INTERIM RESULTS FROM A PHASE IIA STUDY
    Zeng, X.
    Wu, C.
    Hu, J.
    Liu, S.
    Jiang, Z.
    Li, J.
    Wang, X.
    Liu, J.
    Liang, C.
    Yang, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 200 - 200
  • [8] Head-to-Head Comparison of TLL-018 and Tofacitinib in Patients with Active Rheumatoid Arthritis: Final Results from a Phase IIa Study
    Zeng, Xiaofeng
    Wu, Chanyuan
    Hu, Jiankang
    Liu, Shengyun
    Jiang, Zhenyu
    Li, Jingyang
    Wang, Xiaoxia
    Liu, Ju
    Yuan, Chaofan
    Yang, Guang
    Liang, Chris
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1684 - 1686
  • [9] Night-time sedating H1 antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled study
    Grattan, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (01) : 8 - 9
  • [10] Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1-antihistamine treatment: results of the phase IV open-label SUNRISE study
    Berard, F.
    Le Bouedec, M. C. Ferrier
    Bouillet, L.
    Reguiai, Z.
    Barbaud, A.
    Cambazard, F.
    Milpied, B.
    Pelvet, B.
    Kasujee, I.
    Gharbi, H.
    Lacour, J. P.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (01) : 56 - 66
12345